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The prevalence of obesity is increasing in all age groups. According to a 2001 census and the projection
made by the United Nations (1996 revision), the elderly constitute 7.5% of the Indian population, and by
all indications 21% of the Indian population will be 60 years and above by 2050. Medical science dis-
coveries, improved lifestyle, and social conditions during the past few decades have increased the life
span of man. Life expectancy at birth in developed countries is over 70 years. Questions have risen about
the relation between obesity in old age and total or disease-speciﬁc mortality, the deﬁnition of obesity in
the elderly, its clinical relevance, and about the need for its treatment. Information about changes in
body composition and fat distribution among the elderly will help us better understand the relationships
between obesity and morbidity in the elderly.
Copyright  2014, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.1. Introduction
Ageing is a natural and inevitable process. Medical science dis-
coveries, improved lifestyle, and social conditions during the past
few decades have increased the life span of man. Life expectancy at
birth in developed countries is over 70 years.1e3 Global estimation
indicates that there are 605 million people who are older than 65
years.4 The elderly population is the fastest growing segment
throughout the world. In the next 30 years, the elderly population
will increase by up to 300% in Asia and Latin America.5
In India, the proportion of the population in the working age
group, i.e., 15e59 years, and the retired age group of 60 years and
above are both increasing, whereas the age group of 0e14 years is
decreasing. The elderly population (60 years), which accounted
for 6.7% of the total population in 1991, is expected to increase to
more than 10% by the year 2021 (Fig. 1).6
Population aging or increased life expectancy is associated with
the increase in the number of noncommunicable dis-
easesdcoronary heart disease, hypertension, type 2 diabetes mel-
litus (T2DM), osteoarthritis, cataract, urinary incontinence, and
certain types of cancers.7
Obesity is considered one of the major causes of the onset and
severity of noncommunicable diseases. It is a worldwide health
problem at all stages of life in both developed and developingity of Delhi, New Delhi, India.
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linical Gerontology & Geriatrics. Pcountries. In the elderly, it contributes to the early onset of chronic
morbidities and functional impairment, and leads to premature
mortality.8 There is a progressive decline in fat-free mass (FFM)
after the age of 20e30 years. During the period of 20e70 years of
age, up to 40% of FFM (primarily skeletal muscle) decreases,
whereas fat mass increases.9 Fat mass reaches maximum levels at
60e70 years of age and FFM at 20 years of age; both fat measures
subsequently decline thereafter.10 Therefore, both FFM and fat mass
decrease during old age (>70 years).
Redistribution of body fat and FFM is associated with aging.
In comparison to body fat or subcutaneous fat, there is a greater
relative increase in intra-abdominal fat, and because of the loss
of skeletal muscle there is greater decrease in peripheral than in
central FFM.11 In addition, insulin resistance among the elderly
is associated with increased intramuscular and intrahepatic
fat.122. Assessment of obesity among the elderly
Obesity is deﬁned as “an unhealthy excess of body fat, which
increases the risk of medical illness and premature mortality”
(Fig. 2).13 Body mass index (BMI) has been widely used and
accepted as amethod of classifyingmedical risk byweight status. In
most clinical settings, an accurate measurement of body fat mass is
difﬁcult to obtain. BMI is calculated as body weight (in kg) divided
by the square of height (in m). Data from the World Health Orga-
nization (WHO)14 and the National Institutes of Health Heart, Lung,
and Blood Institute15 provide a measure of the relation betweenublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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Fig. 1. Population age structure 1991e2021 in India.
S. Amarya et al. / Journal of Clinical Gerontology & Geriatrics 5 (2014) 63e6764height and weight and correlates results with percentage of body
fat in young and middle-aged adults.
BMI and waist circumference (WC) are adopted based on the
WHO classiﬁcation for assessment of obesity. However, the BMI
classiﬁcation suggested by WHO is not considered suitable for In-
dians and Asians.16 Indians have more body fat than the standard
BMI.17 Indian Reworks Obesity Guideline (2004)17 suggested that
BMI should be reduced for Indians. Hence, BMI (WHO Asia-Paciﬁc
classiﬁcation) is an appropriate measure for Asians in an assess-
ment of obesity. Age-related changes in body composition occurs in
old age (i.e., decreases in FFM and increases in fat mass), and
compression of vertebral bodies and kyphosis (posterior convex
angulation of the spine) result in loss of height. Themajor drawback
of BMI is that it does not differentiate between body fat and FFM
and so, changes in body composition tend to underestimate fatness,
whereas the loss of height would tend to overestimate fatness at
any given BMI. Alternative methods of estimating height, such as
knee height or arm span, have been suggested. This may provide
more reliable estimates of BMI, although these approaches have not
been adequately validated.18,193. Pathogenesis
Table 1 shows that aging is associated with a decrease in all
major components of total energy expenditure (TEE).20 Older men
show 20% less thermic effect as compared to younger men.21 The
relation between energy intake and expenditure is an important
determinant of body fat mass. Therefore, the increase in total fatAltered food 
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Fig. 2. Possible caumass that occurs with aging must be attributable to an increase in
energy intake, a decrease in energy expenditure, or both. Physical
activity decreases with increasing age, and it has been estimated
that decreased physical activity accounts for about one-half of the
decrease in TEE that occurs with aging.22 Therefore, it is likely that a
decrease in TEE is an important contributor to the gradual increase
in body fat with advancing age.
There is an association between aging and decreased growth
hormone secretion. Hormonal changes can enhance the accumu-
lation of fat, the reduction of FFM, and energy balance. The decline
in growth hormone and testosterone production with increasing
age decreases FFM and increases fat mass. Thyroid hormone-
induced oxidative bursts are blunted with aging.23 Moreover,
resistance to leptin could result in a decreased ability to down-
regulate appetite.24
4. Obesity and functional capacity
Obesity has more functional implications as compared to lean in
the older population. Obesity can exacerbate age-related decline in
physical function. Activities of daily living, particularly mobility, is
markedly diminished in the overweight and obese.25,26 BMI is
inversely related to measured physical performance in older per-
sons; a 3-unit increase in BMI is associated with a 1-point decrease
in physical performance test scores.27 In addition, excess body fat
mass and a BMI of 30 in older individuals are associated with
physical dysfunction and are predictive of a decline in functional
status and future disability.28
5. Obesity and associated chronic disorders
Obesity causes serious health complications resulting in
morbidity. The prevalence of several medical complications, such as
diabetes, hypertension, arthritis, cardiovascular disease, urinary
incontinence, and various types of cancers, is associated with
obesity in advancing age.29
6. Metabolic syndrome
Metabolic syndrome and T2DM (formerly noninsulin-
dependent diabetes mellitus or adult-onset diabetes) is the stron-
gest disease associatedwith overweight and obesity.30 According to
the National Institutes of Health (2005),31 the elderly are at an
increased risk of developing intra-abdominal obesity andmetabolicSocial aspects, eating habits, 
smoking, ethnic group, labour-
saving devices, insufficient sleep. 
intake 
Emotional state  Energy Intake  
 Physical Activity 
  Obesity Medication and drugs 
Environmental / Behavioural 
Factors
ses of obesity.
Table 1
Effect of ageing on major components of total energy expenditure (TEE).
Components of TEE Decrease in component
(%) of TEE
Resting metabolic rate 70
Thermic effect of food 10
Physical activity 20
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nisms, and components of the metabolic syndrome (excess
abdominal fat, insulin-resistant glucose metabolism, dyslipidemia,
and high blood pressure) are all prevalent in older populations. The
prevalence of the metabolic syndrome increases with age. There is
a rise after the 3rd decade, reaching a peak in men 50e70 years of
age and inwomen 60e80 years of age.32 Rise in abdominal fat mass
in both men and women aged 70e79 years indicates metabolic
syndrome.33
7. Diabetes
According to the Expert Committee on the Diagnosis and Clas-
siﬁcation of Diabetes and Classiﬁcation of Diabetes Mellitus
(1997),34 after 30 years of age fasting plasma glucose increases by
1e2 mg/dL and postprandial glucose increases by 10e20 mg/dL.35
The prevalence of T2DM is 31.7% in India according to a 2010
report, and it is expected to reach 79.4% by the year 2030.36
8. Hypertension
About 30e50% of the elderly aged 65 years and above are
affected by hypertension.37 Even in old age, obesity and high blood
pressure remain correlated. WC is an independent predictor of
hypertension, and in some studies it was a better predictor of hy-
pertension compared to BMI.38
9. Arthritis
Obesity and arthritis tend to go together. The prevalence in
adults has been reported to vary from 0.5% to 3.8% in women and
from 0.15% to 1.37% in men, with peak incidence in old age.39 If
strain is sustained for a long time in the elderly, it may also lead to
osteoarthritis of weight-bearing joints.39 Arthritis is one big cause
of physical immobility in older adults, resulting in reduced energy
expenditure and high risk of weight gain.40
10. Cardiovascular disease
In recent years, the incidence of coronary artery diseases (CADs)
has shown an increasing trend in India.41 The risk of developing
CAD in the Indian population is much higher than that in other
countries.42,43 Moreover, CAD is the major cause of disability, thus
limiting the activity and eroding the quality of life of millions of
elderly people each year. Generally, cardiometabolic obesity-
related complications are linked to central adiposity, and many
reports show that other than WC obesity is quantiﬁed in terms of
BMI alone, which may potentially mask the association of abdom-
inal fat and cardiovascular disease to events. Various studies sug-
gest that obesity can raise the risk of cardiovascular disease in older
adults. Data from longitudinal population studies44 suggest that
obesity increases the risk of cardiovascular disease in older men,
but not necessarily in older women. Increased BMI in older men
was associated with an increase in new cases of coronary heartdisease, fatal and nonfatal infarction, and cardiovascular disease
mortality during 12e15 years of subsequent observation. However,
no increased cardiovascular disease risk was observed in obese
older women in some, but not all, studies.
11. Pulmonary abnormalities
Obesity, particularly abdominal obesity, is associated with pul-
monary function abnormalities, obesity-hypoventilation syn-
drome, and obstructive sleep apnea.45 In a 5-year prospective
study, older heavier men had the greatest increase in the respira-
tory disturbance index, which is the number of apneas and hypo-
pneas divided by the estimated hours of sleep.46 Increased weight
on the chest wall decreases respiratory compliance, increases the
work of breathing, and restricts ventilation. Older obese men may
be particularly predisposed to developing weight-related sleep
apnea.
12. Cancer
WHO states that overweight and obesity are the most important
known avoidable causes of cancer after tobacco.47The incidence of
cancer increases with age, and more than 12e23% of all cancers
occur after the age of 65 years.48,49 Although more than 25% of
cancers are diagnosed in people over 60 years of age, this group is
less extensively investigated and probably receives less appropriate
treatment. Obesity is associated with an increased risk of several
types of cancer (i.e., breast, colon, gallbladder, pancreas, renal,
bladder, uterine, cervical, and prostate cancers). A pooled analysis
of eight cohort studies of more than 300,000 women has shown
that postmenopausal women with BMI 28 kg/m2 have a 26% in-
crease in the risk of breast cancer compared with those with BMI
<21 kg/m2.50
13. Urinary incontinence
This is a common and distressing problem for the elderly. The
prevalence ranged from 5% to 25% in men and from 7%51 to 42%52 in
women. Obesity contributes to the increase in prevalence of urinary
incontinence in older persons, and the increase in urinary incon-
tinence is directly associated with increased BMI.53
14. Cataracts
India accounts for 20% of the global burden of blindness, with
cataracts being the principal cause.54 Studies based on population
reports show that Indians have a higher prevalence of cataracts
than Western populations.55 Visual impairment associated with
cataract affects nearly 20% of persons aged 65 years.56 Various
studies done on the elderly (60 years and above) indicate that
overweight and obesity are associated with an increased preva-
lence of cataracts and cataract surgery.57
15. Guidelines for treatment
With a brief overview of the health challenges faced by the
elderly population in India, the following strategies may be
explored: improving the quality of life of the geriatric population
and improving physical function. In fact, quality of life may be the
most important goal of therapy in older adults. Among the elderly,
therapeutic approaches focus on preventing loss of muscle and
bone mass that occurs with weight loss in older persons. The cur-
rent therapeutic tools available for weight management in older
persons are described in the following subsections.
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Because elderly patients are mostly on various medications for
other diseases, pharmacologic agents used for the treatment of
obesity can cause additional burdens. Orlistat, a saturated deriva-
tive of lipostatin, is the only licensed antiobesity medication.58 The
gastrointestinal tract does not absorb this medicine. Rather, it binds
to intestinal lipases and thus prevents 30% of dietary fat absorp-
tion.59 Orlistat helps to reduce 8e10% of weight in 1 year. Its
adverse proﬁle is restricted to gastrointestinal effects such as ste-
atorrhea (which occurs if high-fat meals>20 g fat are consumed).60
There is no reason to suppose that its effectiveness or safety would
be any different in elderly patients.61
Sibutramine is another medication. It has recently been with-
drawn in most countries (including the United States and Europe)
because in older adults clinical trial is very high mainly elderly
with active CHD, who fell outside its license. This is a centrally
acting, monoamine reuptake inhibitor, blocking the reuptake of
both serotonin and noradrenaline, thus leading to increased
satiation.62
15.2. Bariatric surgery
Bariatric surgery is the most effective weight-loss therapy for
obesity. Although there are no age guidelines provided, the ma-
jority of patients who undergo bariatric surgery are 60 years or
older.63 Criteria for bariatric surgery are deﬁned as having a BMI of
40 or 35e40 kg/m2 with other signiﬁcant diseases (e.g., sleep ap-
nea, T2DM, high blood pressure) that could be improved by weight
loss. This option requires that the individual must: (1) have failed to
achieve the desired results with all appropriate nonsurgical pro-
cedures to achieve clinically beneﬁcial weight loss for at least 6
months; (2) be generally ﬁt for anesthesia and surgery; and (3)
commit to the need for long-term follow-up.63
16. Concluding remarks
Obesity is a common but increasing problem in the elderly. The
number of obese people is increasing because of the increased
total number of older persons and increase in the percentage of
obese elderly. Its prevalence is lower in extreme old age, but this is
likely to increase in the future. Obesity has important functional
implications in older men and women because of the decline in
physical activity and energy expenditure, which causes frailty or
sarcopenic obesity. Among the elderly, many medical conse-
quences particularly of obesity are problematic (e.g., T2DM,
arthritis, cardiovascular disease, metabolic syndrome, urinary in-
continence, and depression). Chronic inﬂammation and endocrine
changes contribute to the changes in metabolism and body
composition that accompany aging. The focus of treatment should
be on a reduction of intra-abdominal fat initially with modest,
conventional diet restriction, and preservation of muscle mass and
strength through physical activity. Therefore, it is particularly
important to consider weight-loss therapy to improve physical
function in obese older people, in addition to possibly preventing
or improving the medical complications associated with obesity,
which is the major goal of weight-loss therapy in obese young
adults. In addition, the therapeutic approaches must consider the
potential adverse effects of weight loss on muscle and bone
masses.
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